《新股消息》東軟熙康(09686.HK)公開發售認購不足 下限定價4.76元 一手中籤率100%
東軟熙康(09686.HK)公布招股結果,每股發售價定為4.76元,為招股價範圍(4.76至5.91元)下限定價。香港公開發售部分認購不足,僅錄認購約0.9倍。每手500股計,一手中籤率100%人人有份。該股將於明日(28日)掛牌。獨家保薦人為中金。
公司上市引入3名基石投資者,包括寧波市產業基金、海曙投資及亞信科技(01675.HK)主席田溯寧旗下INFO EXPERT,合共認購4,659.2萬股公司股份,佔緊隨股份拆細及全球發售完成後公司已發行股本總額的約5.53%。
此外,公司料上市淨集資約5.55億元,當中約30%擬用於拓展以城市為入口的雲醫院平台;約25%用於豐富在整個行業價值鏈上的產品;約25%用於技術基礎設施及數據能力的研發;約10%用於潛在的併購機會;約10%用於營運資金及一般公司用途。
根據弗若斯特沙利文的資料,東軟熙康打造中國首個以城市為入口的雲醫院平台,並建立一個雲醫院網絡,將地方政府、醫療機構、患者及保險公司聯繫起來,以實現公平地獲取醫療資源並更有效及高效地交付醫療服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.